West Pharmaceutical Services, Inc.
WST
$214.55
$3.961.88%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 404.20M | 484.60M | 490.90M | 446.20M | 601.80M |
| Total Receivables | 569.40M | 575.80M | 566.60M | 502.00M | 543.90M |
| Inventory | 388.70M | 377.00M | 401.20M | 419.20M | 429.90M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 95.20M | 100.70M | 91.90M | 115.60M | 117.30M |
| Total Current Assets | 1.46B | 1.54B | 1.55B | 1.48B | 1.69B |
|
|
|||||
| Total Current Assets | 1.46B | 1.54B | 1.55B | 1.48B | 1.69B |
| Net Property, Plant & Equipment | 1.77B | 1.72B | 1.71B | 1.64B | 1.55B |
| Long-term Investments | 107.50M | 106.00M | 108.80M | 107.30M | 107.60M |
| Goodwill | 107.50M | 106.00M | 108.80M | 107.30M | 107.60M |
| Total Other Intangibles | 10.00M | 10.80M | 12.30M | 12.90M | 13.90M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 64.20M | 70.60M | 75.00M | 53.00M | 40.00M |
| Total Assets | 3.62B | 3.64B | 3.68B | 3.49B | 3.60B |
|
|
|||||
| Total Accounts Payable | 228.40M | 239.30M | 224.30M | 211.70M | 240.10M |
| Total Accrued Expenses | 67.80M | 138.00M | 79.60M | 82.90M | 66.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 22.90M | 18.80M | 20.80M | 154.10M | 151.40M |
| Total Finance Division Other Current Liabilities | 207.60M | 154.30M | 191.80M | 185.00M | 190.40M |
| Total Other Current Liabilities | 207.60M | 154.30M | 191.80M | 185.00M | 190.40M |
| Total Current Liabilities | 526.70M | 550.40M | 516.50M | 633.70M | 648.40M |
|
|
|||||
| Total Current Liabilities | 526.70M | 550.40M | 516.50M | 633.70M | 648.40M |
| Long-Term Debt | 202.60M | 202.60M | 202.60M | 72.90M | 72.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 81.90M | 83.90M | 84.50M | 87.00M | 82.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 123.90M | 124.20M | 119.40M | 119.00M | 118.10M |
| Total Liabilities | 935.10M | 961.10M | 923.00M | 912.60M | 921.70M |
|
|
|||||
| Common Stock & APIC | 20.60M | 40.90M | 42.10M | 52.30M | 74.00M |
| Retained Earnings | 4.03B | 3.96B | 3.86B | 3.72B | 3.62B |
| Treasury Stock & Other | -1.37B | -1.32B | -1.15B | -1.20B | -1.02B |
| Total Common Equity | 2.68B | 2.68B | 2.75B | 2.58B | 2.68B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.68B | 2.68B | 2.75B | 2.58B | 2.68B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.68B | 2.68B | 2.75B | 2.58B | 2.68B |
|
|
|||||